P961: CILTACABTAGENE AUTOLEUCEL, A BCMA-DIRECTED CAR-T CELL THERAPY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: 2-YEAR POST LPI RESULTS FROM THE PHASE 1B/2 CARTITUDE-1 STUDY

• Y. Lin,
• T. Martin,
• J. G. Berdeja,
• A. Jakubowiak,
• M. Agha,
• A. D. Cohen,
• A. Deol,
• M. Htut,
• A. Lesokhin,
• N. C. Munshi,
• E. O’Donnell,
• C. C. Jackson,
• T.-M. Yeh,
• A. Banerjee,
• E. Zudaire,
• D. Madduri,
• C. Zhou,
• L. Pacaud,
• S. Z. Usmani,
• S. Jagannath

Affiliations

Y. Lin

1 Mayo Clinic, Rochester, MN

T. Martin

2 UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA

J. G. Berdeja

3 Sarah Cannon Research Institute, Nashville, TN

A. Jakubowiak

4 University of Chicago, Chicago, IL

M. Agha

5 UPMC Hillman Cancer Center, Pittsburgh, PA

A. D. Cohen

6 Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA

A. Deol

7 Karmanos Cancer Institute, Wayne State University, Detroit, MI

M. Htut

8 City of Hope Comprehensive Cancer Center, Duarte, CA

A. Lesokhin

9 Memorial Sloan Kettering Cancer Center, New York, NY

N. C. Munshi

10 Dana-Farber Cancer Institute, Harvard Medical School

E. O’Donnell

11 Massachusetts General Hospital, Harvard Medical School, Boston, MA

C. C. Jackson

12 Janssen R&D, Raritan, NJ

T.-M. Yeh

12 Janssen R&D, Raritan, NJ

A. Banerjee

13 Janssen R&D, Spring House, PA

E. Zudaire

13 Janssen R&D, Spring House, PA

D. Madduri

12 Janssen R&D, Raritan, NJ

C. Zhou

14 Legend Biotech USA, Piscataway, NJ

L. Pacaud

14 Legend Biotech USA, Piscataway, NJ

S. Z. Usmani

9 Memorial Sloan Kettering Cancer Center, New York, NY

S. Jagannath

15 Mount Sinai Medical Center, New York, NY, United States of America